{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T21:03:28Z","timestamp":1765832608951,"version":"3.48.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008788","name":"College of Veterinary Medicine, Ohio State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008788","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ajogmf.2025.101701","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T12:00:20Z","timestamp":1747396820000},"page":"101701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Meaningful clinical outcomes: perspectives of primary caregivers with lived experience of spontaneous preterm birth following spontaneous preterm labor"],"prefix":"10.1016","volume":"7","author":[{"given":"Elizabeth","family":"Gargon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4111-4181","authenticated-orcid":false,"given":"Rosie","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anya","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien J.","family":"Croft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Roset Bahmanyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara M.","family":"Rood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0586-3019","authenticated-orcid":false,"given":"Vanessa","family":"Perez Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2025.101701_bib0001","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2352-4642(21)00311-4","article-title":"Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the Sustainable Development Goals","volume":"6","author":"Perin","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0002","unstructured":"US Food and Drug Administration. Advancing drug development for the prevention of spontaneous preterm birth. 2024. Available at: https:\/\/fda.gov\/drugs\/news-events-human-drugs\/advancing-drug-development-prevention-spontaneous-preterm-birth-01232024. Accessed February 20, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0003","unstructured":"Robinson JN, Norwitz ER. Spontaneous preterm birth: overview of risk factors and prognosis. 2024. Available at:https:\/\/uptodate.com\/contents\/spontaneous-preterm-birth-overview-of-risk-factors-and-prognosis. Accessed February 19, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(08)60136-1","article-title":"An overview of mortality and sequelae of preterm birth from infancy to adulthood","volume":"371","author":"Saigal","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0005","unstructured":"Ross MG. Preterm labor. 2021. Available at: https:\/\/emedicine.medscape.com\/article\/260998-overview?form=fpf. Accessed February 20, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0006","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) resource. 2021. Available at:https:\/\/health.uconn.edu\/pepper-center\/wp-content\/uploads\/sites\/272\/2023\/12\/best-biomarkers-endpoints-and-other-tools-resource.pdf. Accessed October 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0007","unstructured":"US Food and Drug Administration. Pregnant women: scientific and ethical considerations for inclusion in clinical trials - draft guidance for industry. 2018. Available at:https:\/\/fda.gov\/files\/drugs\/published\/Pregnant-Women\u2013Scientific-and-Ethical-Considerations-for-Inclusion-in-Clinical-Trials.pdf. Accessed February 20, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0008","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/j.semperi.2016.09.009","article-title":"Measuring and communicating meaningful outcomes in neonatology: a family perspective","volume":"40","author":"Janvier","year":"2016","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/archdischild-2019-316823","article-title":"Inconsistent outcome reporting in large neonatal trials: a systematic review","volume":"105","author":"Webbe","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0010","unstructured":"Duke-Margolis Institute for Health Policy, US Food and Drug Administration. Advancing drug development for the prevention of spontaneous preterm birth. 2024. Available at:https:\/\/healthpolicy.duke.edu\/sites\/default\/files\/2024-01\/preterm%20birth%20workshop%20slide%20deck.pdf. Accessed February 20, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0011","unstructured":"US Food and Drug Administration. Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments - draft guidance for industry, Food and Drug Administration staff, and other stakeholders. 2022. Available at: https:\/\/fda.gov\/media\/159500\/download. Accessed February 14, 2023."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11648\/j.ajtas.20160501.11","article-title":"Comparison of convenience sampling and purposive sampling","volume":"5","author":"Etikan","year":"2016","journal-title":"Am J Theor Appl Stat"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0013","unstructured":"Eunice Kennedy Shriver National Institute of Child Health and Human Development. What are the risk factors for preterm labor and birth? 2023. Available at:https:\/\/nichd.nih.gov\/health\/topics\/preterm\/conditioninfo\/who_risk#f4. Accessed February 9, 2023."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0014","unstructured":"March of Dimes. Preterm birth. 2024. Available at:https:\/\/marchofdimes.org\/peristats\/data?top=3&lev=1&stop=55&reg=99&obj=3&slev=1. Accessed February 22, 2023."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0015","unstructured":"US Food and Drug Administration. Patient-focused drug development: methods to identify what is important to patients - guidance for industry, Food and Drug Administration staff, and other stakeholders. 2022. Available at: https:\/\/fda.gov\/media\/131230\/download. Accessed September 2, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0016","unstructured":"AMAG Pharmaceuticals Inc. Confirmatory study of 17P vs vehicle for prevention of preterm birth in women w\/previous spontaneous preterm delivery (PROLONG). 2009. Available at: https:\/\/clinicaltrials.gov\/study\/NCT01004029. Accessed March 26, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0017","unstructured":"Caritis SN. Relationship between plasma concentration of hydroxyprogesterone caproate (17-OHPC) and preterm birth (PRO). 2018. Available at: https:\/\/clinicaltrials.gov\/study\/NCT03292731. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0018","unstructured":"GSK. A Phase III efficacy and safety study of intravenous retosiban versus placebo for women in spontaneous preterm labor (NEWBORN-1). 2015. Available at: https:\/\/clinicaltrials.gov\/study\/NCT02377466. Accessed March 20, 2023."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0019","unstructured":"GSK. A randomized study comparing the efficacy and safety of retosiban versus atosiban for women in spontaneous preterm labour. 2015. Available at: https:\/\/clinicaltrials.gov\/study\/NCT02292771. Accessed September 11, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0020","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"New Eng J Med"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0021","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1055\/s-0038-1635097","article-title":"A retrospective database analysis of neonatal morbidities to evaluate a composite endpoint for use in preterm labor clinical trials","volume":"8","author":"Pimenta","year":"2018","journal-title":"Am J Perinatol Rep"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0022","unstructured":"US Food and Drug Administration. Final decision on the proposal to withdraw approval of Makena. 2023. Available at:https:\/\/downloads.regulations.gov\/FDA-2020-N-2029-0385\/attachment_1.pdf. Accessed September 11, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0023","unstructured":"ATLAS.ti Scientific software development GmbH. ATLAS.ti windows software version 22. 2022. Available at: https:\/\/atlasti.com\/atlas-ti-desktop. Accessed February 2, 2023."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0024","unstructured":"Fetal Medicine Foundation. Oral progesterone for prevention of preterm birth. 2006. Available at: https:\/\/clinicaltrials.gov\/study\/NCT01180296. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0025","unstructured":"Juniper Pharmaceuticals Inc. Vaginal progesterone to reduce the risk of another preterm birth. 2004. Available at: https:\/\/clinicaltrials.gov\/study\/NCT00086177. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0026","unstructured":"Juniper Pharmaceuticals Inc. PREGNANT short cervix trial. 2008. Available at: https:\/\/clinicaltrials.gov\/study\/NCT00615550. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0027","unstructured":"Obstetrix Medical Group. A randomized trial comparing the impact of one versus two courses of antenatal steroids (ACS) on neonatal outcome (ACS). 2003. Available at: https:\/\/clinicaltrials.gov\/study\/NCT00201643. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0028","unstructured":"Pediatrix. Impact of a booster course of antenatal steroids on neonatal outcome in patients with premature rupture of the membranes (ACSinPROM). 2016. Available at: https:\/\/clinicaltrials.gov\/study\/NCT02469519. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0029","unstructured":"Thomas Jefferson University. Vaginal versus intramuscular progesterone for the prevention of recurrent preterm birth (VIP). 2016. Available at: https:\/\/clinicaltrials.gov\/study\/NCT02913495. Accessed 3 April 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0030","unstructured":"University of Kansas Medical Center. Assessment of DHA on reducing early preterm birth (ADORE). 2016. Available at: https:\/\/clinicaltrials.gov\/study\/NCT02626299. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0031","unstructured":"GSK. The safety, tolerability and metabolism of GSK221149A, in pregnant women (30-36 weeks), in pre-term labor. 2007. Available at: https:\/\/clinicaltrials.gov\/study\/NCT00404768. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0032","unstructured":"Stanford University. Indomethacin versus nifedipine for preterm labor tocolysis. 2007. Available at: https:\/\/clinicaltrials.gov\/study\/NCT00486824. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0033","unstructured":"University of Texas Southwestern Medical Center. Nifedipine for acute tocolysis of preterm labor (Nifedipine). 2014. Available at: https:\/\/clinicaltrials.gov\/study\/NCT02132533. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0034","unstructured":"The University of Texas Medical Branch Galveston. Treatment of ppROM with erythromycin vs. azithromycin trial (TREAT). 2017. Available at: https:\/\/clinicaltrials.gov\/study\/NCT03060473. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0035","unstructured":"Thomas Jefferson University. Azithromycin dose and PPROM treatment: a pilot randomized controlled trial (ADAPT). 2020. Available at: https:\/\/clinicaltrials.gov\/study\/NCT04294069. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0036","unstructured":"Obstetrix Medical Group. Progesterone (17P, Makena\u00ae) for prolongation of pregnancy in women with preterm rupture of the membranes (PROM) (17PinPROM). 2011. Available at: https:\/\/clinicaltrials.gov\/study\/NCT01119963. Accessed April 3, 2024."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0037","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/AOG.0000000000001195","article-title":"A core outcome set for evaluation of interventions to prevent preterm birth","volume":"127","author":"van't Hooft","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0038","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/archdischild-2019-317501","article-title":"Core outcomes in neonatology: development of a core outcome set for neonatal research","volume":"105","author":"Webbe","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0039","unstructured":"University of Utah Health. When is it safe to deliver your baby? 2025. Available at: https:\/\/healthcare.utah.edu\/womens-health\/pregnancy-birth\/preterm-birth\/when-is-it-safe-to-deliver. Accessed February 3, 2025."},{"key":"10.1016\/j.ajogmf.2025.101701_bib0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pedhc.2016.04.009","article-title":"The lived experiences of transition to parenthood for parents of preterm infants","volume":"30","author":"Davies Rieves","year":"2016","journal-title":"J Pediatr Health Care"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0041","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jnn.2012.08.002","article-title":"The journey towards motherhood after a very preterm birth: mothers' experiences in hospital and after home-coming","volume":"19","author":"Hall","year":"2013","journal-title":"J Neonatal Nurs"},{"year":"2013","series-title":"Distress after preterm birth: a discourse analysis of parents' accounts and photographs [unpublished doctoral dissertation]","author":"Kantrowitz-Gordon","key":"10.1016\/j.ajogmf.2025.101701_bib0042"},{"year":"2012","series-title":"Narrative creation as an aspect of coping in response to preterm delivery and hospitalization [unpublished doctoral dissertation]","author":"Bronzo","key":"10.1016\/j.ajogmf.2025.101701_bib0043"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0044","first-page":"1","article-title":"The experience of woman from rural Australia with a preterm infant in a neonatal intensive care unit","volume":"23","author":"Laidlaw","year":"2023","journal-title":"Rural Remote Health"},{"year":"2014","series-title":"The experience of Asian mothers who have had a premature infant [unpublished doctoral dissertation]","author":"Chon","key":"10.1016\/j.ajogmf.2025.101701_bib0045"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0046","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/bcp.13166","article-title":"Composite endpoints and the distortion of risk-benefit analysis","volume":"83","author":"Warren","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1121406","article-title":"Risk factors for length of NICU stay of newborns: a systematic review","volume":"11","author":"Fu","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0048","doi-asserted-by":"crossref","first-page":"e2279","DOI":"10.1002\/hsr2.2279","article-title":"Surrogate endpoints for neonatal outcome: a rapid review","volume":"7","author":"El Adam","year":"2024","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.glmedi.2024.100051","article-title":"The pillars of trustworthiness in qualitative research","volume":"2","author":"Ahmed","year":"2024","journal-title":"J Med Surg Public Health"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0050","first-page":"1","article-title":"Very preterm infants engage in an intervention to train their control of attention: results from the feasibility study of the Attention Control Training (ACT) randomised trial","volume":"7","author":"Perra","year":"2021","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.ajogmf.2025.101701_bib0051","unstructured":"March of Dimes. Prematurity profile: United States. 2022. Available at:https:\/\/marchofdimes.org\/peristats\/assets\/s3\/reports\/prematurity\/prematurityprofile-unitedstates.pdf. Accessed February 20, 2024."}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933325001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933325001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:57:30Z","timestamp":1765832250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933325001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2589933325001016"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2025.101701","relation":{},"ISSN":["2589-9333"],"issn-type":[{"type":"print","value":"2589-9333"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meaningful clinical outcomes: perspectives of primary caregivers with lived experience of spontaneous preterm birth following spontaneous preterm labor","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2025.101701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101701"}}